ATRS News and Press, Antares Pharma Inc. From 07/22/21

EWING, N.J., July 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug Application (IND) for ATRS-1902 fo...

EWING, N.J., July 07, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to present at the Ladenburg Thalmann Annual Healthc...

Current & Former Biotech Penny Stocks To Watch This Week Is the stock market going to crash? What are the best penny stocks to buy right now? Will July bring new highs in the stock market in 2021? These are just a few of the many questions being asked as we embark on the second ...

EWING, N.J., June 28, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that its partner Idorsia Ltd (“Idorsia”) initiated its Phase 3 registration study to evaluate the efficacy and ...

EWING, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the ...

EWING, N.J., June 15, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to present at the Raymond James Human Health Innova...

The share price received a timely boost from first quarter numbers. We do not believe the momentum has stopped here. Prescriptions from XYOSTED and EpiPen continue to drive sales forward. We expect another attempt to take out the $5 level sooner rather than later. For fu...

Antares Pharma, Inc. (ATRS) Q1 2021 Earnings Conference Call May 06, 2021, 08:30 ET Company Participants Tram Bui - VP, Corporate Communications & IR Robert Apple - CEO, President & Director Fred Powell - EVP & CFO Conference Call Participants Briana Warschun - Jefferies Lucas Lee...

The following slide deck was published by Antares Pharma, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Antares Pharma, Inc. 2021 Q1 - Results - Earnings Call Presentation

Antares Pharma (ATRS) posted first-quarter results that beat Wall Street estimates, as the company benefited from an increase in prescriptions and patient visits due to the slowdown of the COVID-19 pandemic.The company also reaffirmed FY 2021 revenue guidance in the range of $175M-200M, which...